Interventional Neuroradiology Market is valued at USD 2305.2 Million in 2021 and expected to reach USD 3425.2 Million by 2028 with a CAGR of 5.82% over the forecast period.
The increasing preference for minimally invasive procedures with the growing prevalence of chronic diseases are driving the Global Interventional Neuroradiology Market.
Interventional Neuroradiology (INR) is also known as neuro endovascular therapy and is a medical sub-domain of radiology specifying slightly offensive image-based techniques and procedures used in diagnosis and treatment of diseases related to neck, head and spine. This therapy is focusing on the diagnosis and characterization of abnormalities of the peripheral and central nervous system, head, spine and neck by using neuroimaging techniques. Interventional neurology has undergone a prompt evolution in past 2-3 decades due to the continuing advances in imaging technology and the introduction of new tools, including more traceable microcatheters and safer embolic materials. Currently, neuroradiological techniques play vital roles in the diagnosis of brain arteriovenous malformation (AVM), cerebral aneurysm, Carotid-cavernous fistula (CCF), head and neck tumors, meningioma, nosebleeds, strokes and vertebral body tumors. As compared to open surgical methods, this method offers minimally invasive substitutes for various head and neck disorders. The head and neck interventions can be executed through percutaneous, endovascular or an arrangement of these two.
Some major key players for interventional neuroradiology market are -
Interventional Neuroradiology market report is segmented on the basis of product, disease, end-user and region & country level. Based upon product, interventional neuroradiology market is segmented into neurovascular embolization and coiling assist devices, embolic coils, flow diversion devices, liquid embolic agents, accessories, micro catheters, microguidewires and others. Based on disease, market is segmented into cerebral aneurysms, intra-cranial tumors, acute strokes and other. Based upon end-user, interventional neuroradiology market is segmented into hospitals, ambulatory surgical centers and others.
Increasing technological advancements in neuroradiology such as; developments of different microcatheters, embolic agents, guidewires, high resolution imaging tools and therapeutic techniques is the major factor driving the growth of market. In addition, increasing preference for minimally invasive procedures with the growing incidences of chronic diseases, increase in geriatric population are some of the factors that are supporting the growth of the market. High demand for MI (multiple imputations) procedures is also playing a supportive role in the market growth. However, long term therapeutic efficiency or risk benefit calculations in microsurgery, deficiency of IR consultants in the field of neuroradiology and entry hurdles for new players are the factors which may act as the barriers for market growth.
Moreover, rapid progress in neuroradiology has provided the new therapeutic applications in the difficult diseases of brain and neck, steady and objective evaluation in neuroradiology which can create new revenue opportunities for the interventional neuroradiology market.
The interventional neuroradiology market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is expected to dominate the interventional neuroradiology market owing to the cost effective diagnosis, growing occurrence of chronic diseases and high demand of minimally invasive technologies in this region. Additionally, high acceptance of technologically advanced medical devices and well established healthcare groundwork are supporting the growth in North America. Asia-Pacific is expecting to be the fastest region within forecast period due to the swift developments in healthcare infrastructure in the emerging economies such as India and china.
|2016 - 2021
|2022 - 2029
|Market Size in 2021:
|USD 2305.2 Million
|Base year considered
|Forecast Period CAGR %:
|Market Size Expected in 2028:
|USD 3425.2 Million
|Tables, Charts & Figures:
|Allina Health, Balt Extrusion, Boston Scientific Corporation, Codman neuro, DePuy Synthes, Fujifilm Healthcare, GE Healthcare, Gore & Associates, Medtronic, Merit Medical Systems, MicroPort Scientific Corporation, Penumbra Inc., Siemens Healthineers, Stryker, Terumo Corporation, Others..
|By Product, By Disease, By End-User
|North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®